China News Service, April 11 (Xinhua) According to the website of the Inner Mongolia Health and Welfare Committee, as of 24:00 on April 10, the Inner Mongolia Autonomous Region has no new confirmed cases of local new coronary pneumonia and no new suspected cases of local new coronary pneumonia for 52 consecutive days.

From 7:00 on April 10 to 9:00 on April 11, the Inner Mongolia Autonomous Region reported the addition of 27 confirmed cases and 1 suspected case of imported new coronary pneumonia. 8 suspected cases were excluded.

Among them, 27 confirmed cases and one suspected case were from Russia. After entering Manzhouli highway port, they were screened according to the requirements of the new coronary pneumonia epidemic control of the inbound personnel. After consultation with experts, they were diagnosed as new coronary cases and suspected cases. They are all isolated and treated in Manzhouli City People's Hospital and Zhalai Nuoer District People's Hospital, and closed-loop management is implemented throughout.

Of the 8 suspected cases excluded, 7 were cases in which international flights from Capital Airport were diverted to Hohhot Baita International Airport, and the other case was an inbound case via Guangzhou.

As of 9:00 on April 11, the Inner Mongolia Autonomous Region has reported a total of 80 confirmed cases of imported new coronary pneumonia, 30 suspected cases, and 5 cured cases. Of the 80 confirmed cases of imported new coronary pneumonia, 36 were from Russia, 22 from the UK, 19 from France, 2 from the United States, and 1 from Spain.

In Manzhouli, Hulunbeier, 27 newly diagnosed cases and 1 suspected case were newly imported from abroad. In Manzhouli City of Hulunbuir City, 36 cases of newly diagnosed new coronary pneumonia and 12 cases of suspected cases were imported from abroad.

As of 24:00 on April 10, Inner Mongolia Autonomous Region reported 0 cases of asymptomatic infection.

All of the above patients received isolation treatment in designated hospitals, all close contacts were concentrated in isolated medical observations at designated locations, and closed-loop management was implemented throughout the entire process.